{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:15:18Z","timestamp":1778721318466,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Radical segmentectomy has been performed for small-sized non-small cell lung cancer (NSCLC). However, underestimation of mediastinal lymph node metastasis in the absence of hilar or interlobar metastasis (skip N2) affects surgical strategy. Our aim was to investigate preoperative and intraoperative predictors of skip N2 in clinical stage (c-stage) IA NSCLC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>From 1998 to 2011, 279 patients (155 men and 124 women) with c-stage IA NSCLC (230 pN0, 17 pN1, 12 skip N2, 20 non-skip N2) underwent systematic lobectomy (R0 resection) at our institute. We compared preoperative serum concentrations of carcinoembryonic antigen, cytokeratin 19 fragment, sialyl Lewis X (SLX), and pre- and intraoperative clinicopathological features of pN0 and skip N2 patients. Receiver operator characteristic (ROC) curve analysis was performed to distinguish between the two patient groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The 5-year survival rate of skip N2 patients was 78.6%, higher than that of non-skip N2 patients (44.9%), and not significantly different than that of pN0 (86.7%) or pN1 patients (82.4%). The mean serum SLX concentration in skip N2 patients (28.0 U\/ml) was elevated compared to that in pN0 patients (22.9 U\/ml). In ROC analysis of SLX, the area under the curve was 0.710, and the optimal cut-off value was 21.4 U\/ml (sensitivity, 91.7%; specificity, 51.7%). In multivariate analysis, SLX was an independent predictor of skip N2 in patients with c-stage IA NSCLC (odds ratio, 9.43; <jats:italic>p<\/jats:italic>\u2009=\u20090.006).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Skip N2 metastasis is common in patients with c-stage IA NSCLC with high serum SLX, and lobectomy with complete dissection of hilar and mediastinal lymph nodes should remain the standard surgical procedure for these cases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-7819-11-309","type":"journal-article","created":{"date-parts":[[2013,12,6]],"date-time":"2013-12-06T02:08:16Z","timestamp":1386295696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Sialyl Lewis X as a predictor of skip N2 metastasis in clinical stage IA non-small cell lung cancer"],"prefix":"10.1186","volume":"11","author":[{"given":"Hiroaki","family":"Komatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinjiro","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyukwang","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigefumi","family":"Suehiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noritoshi","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,6]]},"reference":[{"key":"1498_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 2007, 57: 43-66. 10.3322\/canjclin.57.1.43.","journal-title":"CA Cancer J Clin"},{"key":"1498_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/01243894-200605000-00002","volume":"1","author":"P Goldstraw","year":"2006","unstructured":"Goldstraw P, Crowley JJ, IASLC International Staging Project: The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer. J Thorac Oncol. 2006, 1: 281-286. 10.1097\/01243894-200605000-00002.","journal-title":"J Thorac Oncol"},{"key":"1498_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/01243894-200602000-00004","volume":"1","author":"T Fukui","year":"2006","unstructured":"Fukui T, Mori S, Yokoi K, Mitsudomi T: Significance of number of positive lymph nodes in resected non-small cell lung cancer. J Thorac Oncol. 2006, 1: 120-125. 10.1097\/01243894-200602000-00004.","journal-title":"J Thorac Oncol"},{"key":"1498_CR4","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/S1010-7940(99)00178-5","volume":"16","author":"T Naruke","year":"1999","unstructured":"Naruke T, Tsuchiya R, Kondo H, Nakayama H, Asamura H: Lymph node sampling in lung cancer: how should it be done?. Eur J Cardiothorac Surg. 1999, 16: S17-S24.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1498_CR5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/0003-4975(95)00537-U","volume":"60","author":"RJ Ginsberg","year":"1995","unstructured":"Ginsberg RJ, Rubinstein LV: Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995, 60: 615-622. 10.1016\/0003-4975(95)00537-U. discussion 622\u20133","journal-title":"Ann Thorac Surg"},{"key":"1498_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/icvts\/ivr065","volume":"14","author":"M Okada","year":"2012","unstructured":"Okada M, Tsutani Y, Ikeda T, Misumi K, Matsumoto K, Yoshimura M, Miyata Y: Radical hybrid video-assisted thoracic segmentectomy: long-term results of minimally invasive anatomical sublobar resection for treating lung cancer. Interact Cardiovasc Thorac Surg. 2012, 14: 5-11. 10.1093\/icvts\/ivr065.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"1498_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/ejcts\/ezr254","volume":"42","author":"S Yamashita","year":"2012","unstructured":"Yamashita S, Tokuishi K, Anami K, Moroga T, Miyawaki M, Chujo M, Yamamoto S, Kawahara K: Thoracoscopic segmentectomy for T1 classification of non-small cell lung cancer: a single center experience. Eur J Cardiothorac Surg. 2012, 42: 83-88. 10.1093\/ejcts\/ezr254.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1498_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jss.2009.04.006","volume":"166","author":"S Yamashita","year":"2011","unstructured":"Yamashita S, Chujo M, Kawano Y, Miyawaki M, Tokuishi K, Anami K, Yamamoto S, Kawahara K: Clinical impact of segmentectomy compared with lobectomy under complete video-assisted thoracic surgery in the treatment of stage I non-small cell lung cancer. J Surg Res. 2011, 166: 46-51. 10.1016\/j.jss.2009.04.006.","journal-title":"J Surg Res"},{"key":"1498_CR9","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.athoracsur.2012.03.080","volume":"94","author":"CF Yang","year":"2012","unstructured":"Yang CF, D'Amico TA: Thoracoscopic segmentectomy for lung cancer. Ann Thorac Surg. 2012, 94: 668-681. 10.1016\/j.athoracsur.2012.03.080.","journal-title":"Ann Thorac Surg"},{"key":"1498_CR10","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.athoracsur.2011.05.091","volume":"92","author":"BA Whitson","year":"2011","unstructured":"Whitson BA, Groth SS, Andrade RS, Maddaus MA, Habermann EB, D'Cunha J: Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis. Ann Thorac Surg. 2011, 92: 1943-1950. 10.1016\/j.athoracsur.2011.05.091.","journal-title":"Ann Thorac Surg"},{"key":"1498_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/jjco\/hyp156","volume":"40","author":"K Nakamura","year":"2010","unstructured":"Nakamura K, Saji H, Nakajima R, Okada M, Asamura H, Shibata T, Nakamura S, Tada H, Tsuboi M: A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802\/WJOG4607L). Jpn J Clin Oncol. 2010, 40: 271-274. 10.1093\/jjco\/hyp156.","journal-title":"Jpn J Clin Oncol"},{"key":"1498_CR12","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.athoracsur.2012.02.093","volume":"93","author":"T Koike","year":"2012","unstructured":"Koike T, Koike T, Yamato Y, Yoshiya K, Toyabe S: Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy. Ann Thorac Surg. 2012, 93: 1788-1794. 10.1016\/j.athoracsur.2012.02.093.","journal-title":"Ann Thorac Surg"},{"key":"1498_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.athoracsur.2012.04.047","volume":"94","author":"C Zhong","year":"2012","unstructured":"Zhong C, Fang W, Mao T, Yao F, Chen W, Hu D: Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer. Ann Thorac Surg. 2012, 94: 362-367. 10.1016\/j.athoracsur.2012.04.047.","journal-title":"Ann Thorac Surg"},{"key":"1498_CR14","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jtcvs.2011.10.045","volume":"143","author":"H Nomori","year":"2012","unstructured":"Nomori H, Mori T, Izumi Y, Kohno M, Yoshimoto K, Suzuki M: Is completion lobectomy merited for unanticipated nodal metastases after radical segmentectomy for cT1 N0 M0\/pN1-2 non-small cell lung cancer?. J Thorac Cardiovasc Surg. 2012, 143: 820-824. 10.1016\/j.jtcvs.2011.10.045.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1498_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jtcvs.2012.03.034","volume":"144","author":"H Nomori","year":"2012","unstructured":"Nomori H, Mori T, Ikeda K, Yoshimoto K, Iyama K, Suzuki M: Segmentectomy for selected cT1N0M0 non-small cell lung cancer: a prospective study at a single institute. J Thorac Cardiovasc Surg. 2012, 144: 87-93. 10.1016\/j.jtcvs.2012.03.034.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1498_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5761\/atcs.oa.11.01726","volume":"18","author":"T Moroga","year":"2012","unstructured":"Moroga T, Yamashita S, Tokuishi K, Miyawaki M, Anami K, Yamamoto S, Kawahara K: Thoracoscopic segmentectomy with intraoperative evaluation of sentinel nodes for stage I non-small cell lung cancer. Ann Thorac Cardiovasc Surg. 2012, 18: 89-94. 10.5761\/atcs.oa.11.01726.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"1498_CR17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/jso.10219","volume":"82","author":"KL Prenzel","year":"2003","unstructured":"Prenzel KL, M\u00f6nig SP, Sinning JM, Baldus SE, Gutschow CA, Grass G, Schneider PM, H\u00f6lscher AH: Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer. J Surg Oncol. 2003, 82: 256-260. 10.1002\/jso.10219.","journal-title":"J Surg Oncol"},{"key":"1498_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.athoracsur.2004.06.081","volume":"79","author":"M Riquet","year":"2005","unstructured":"Riquet M, Assouad J, Bagan P, Foucault C, Le Pimpec Barthes F, Dujon A, Danel C: Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Ann Thorac Surg. 2005, 79: 225-233. 10.1016\/j.athoracsur.2004.06.081.","journal-title":"Ann Thorac Surg"},{"key":"1498_CR19","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S1010-7940(01)01135-6","volume":"21","author":"Z Gunluoglu","year":"2002","unstructured":"Gunluoglu Z, Solak O, Metin M, Gurses A: The prognostic significance of skip mediastinal lymphatic metastasis in resected non-small cell lung cancer. Eur J Cardiothorac Surg. 2002, 21: 595-10.1016\/S1010-7940(01)01135-6.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1498_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1053\/ejso.2002.1321","volume":"29","author":"J Gawrychowski","year":"2003","unstructured":"Gawrychowski J, Gabriel A, Lackowska B: Heterogeneity of stage IIIA non-small cell lung cancers (NSCLC) and evaluation of late results of surgical treatment. Eur J Surg Oncol. 2003, 29: 178-184. 10.1053\/ejso.2002.1321.","journal-title":"Eur J Surg Oncol"},{"key":"1498_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ejcts.2004.01.025","volume":"25","author":"P Misthos","year":"2004","unstructured":"Misthos P, Sepsas E, Athanassiadi K, Kakaris S, Skottis I: Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer. Eur J Cardiothorac Surg. 2004, 25: 502-508. 10.1016\/j.ejcts.2004.01.025.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1498_CR22","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1097\/JTO.0b013e318158d471","volume":"2","author":"N Ilic","year":"2007","unstructured":"Ilic N, Petricevic A, Arar D, Kotarac S, Banovic J, Ilic NF, Tripkovic A, Grandic L: Skip mediastinal nodal metastases in the in the IIIa\/N2 non-small cell lung cancer. J Thorac Oncol. 2007, 2: 1018-1021. 10.1097\/JTO.0b013e318158d471.","journal-title":"J Thorac Oncol"},{"key":"1498_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1053\/j.ro.2005.01.001","volume":"40","author":"MB Beasley","year":"2005","unstructured":"Beasley MB, Brambilla E, Travis WD: The 2004 World Health Organization classification of lung tumors. Semin Roentgenol. 2005, 40: 90-97. 10.1053\/j.ro.2005.01.001.","journal-title":"Semin Roentgenol"},{"key":"1498_CR24","volume-title":"TMN Classification of Malignant Tumours","author":"LH Sobin","year":"2009","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C: TMN Classification of Malignant Tumours. 2009, Oxford: Wiley-Blackwell, 7","edition":"7"},{"key":"1498_CR25","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/JTO.0b013e3181a0d82e","volume":"4","author":"VW Rusch","year":"2009","unstructured":"Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P, Members of IASLC Staging Committee: The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2009, 4: 568-577. 10.1097\/JTO.0b013e3181a0d82e.","journal-title":"J Thorac Oncol"},{"key":"1498_CR26","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.ejcts.2010.01.012","volume":"37","author":"S Kim","year":"2010","unstructured":"Kim S, Kim HK, Kang DY, Jeong JM, Choi YH: Intra-operative sentinel lymph node identification using a novel receptor-binding agent (technetium-99\u00a0m neomannosyl human serum albumin, 99mTc-MSA) in stage I non-small cell lung cancer. Eur J Cardiothorac Surg. 2010, 37: 1450-1456. 10.1016\/j.ejcts.2010.01.012.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1498_CR27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0022-5223(19)34555-6","volume":"97","author":"M Riquet","year":"1989","unstructured":"Riquet M, Hidden G, Debesse B: Direct lymphatic drainage of lung segments to the mediastinal nodes. An anatomic study on 260 adults. J Thorac Cardiovasc Surg. 1989, 97: 623-632.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1498_CR28","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/S0022-5223(99)70246-1","volume":"117","author":"H Asamura","year":"1999","unstructured":"Asamura H, Nakayama H, Kondo H, Tsuchiya R, Naruke T: Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. Thorac Cardiovasc Surg. 1999, 117: 1102-1111. 10.1016\/S0022-5223(99)70246-1.","journal-title":"Thorac Cardiovasc Surg"},{"key":"1498_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1067\/mtc.2002.122298","volume":"124","author":"H Matsuguma","year":"2002","unstructured":"Matsuguma H, Yokoi K, Anraku M, Kondo T, Kamiyama Y, Mori K, Tominaga K, Tsuura Y, Honjo S: Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis. J Thorac Cardiovasc Surg. 2002, 124: 278-284. 10.1067\/mtc.2002.122298.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1498_CR30","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/JTO.0b013e31821038ab","volume":"6","author":"K Suzuki","year":"2011","unstructured":"Suzuki K, Koike T, Asakawa T, Kusumoto M, Asamura H, Nagai K, Tada H, Mitsudomi T, Tsuboi M, Shibata T, Fukuda H, Kato H, Japan Lung Cancer Surgical Study Group (JCOG LCSSG): A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol. 2011, 6: 751-756. 10.1097\/JTO.0b013e31821038ab.","journal-title":"J Thorac Oncol"},{"key":"1498_CR31","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/S0003-4975(00)02649-7","volume":"71","author":"D Manac'h","year":"2001","unstructured":"Manac'h D, Riquet M, Medioni J, Le Pimpec-Barthes F, Dujon A, Danel C: Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor. Ann Thorac Surg. 2001, 71: 1088-1093. 10.1016\/S0003-4975(00)02649-7.","journal-title":"Ann Thorac Surg"},{"key":"1498_CR32","first-page":"664","volume":"40","author":"A Yilmaz","year":"2011","unstructured":"Yilmaz A, Duyar SS, Cakir E, Aydin E, Demirag F, Karakaya J, Yazici U, Erdogan Y: Clinical impact of visceral pleural, lymphovascular and perineural invasion in completely resected non-small cell lung cancer. Eur J Cardiothorac Surg. 2011, 40: 664-670.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1498_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/1097-0142(19910701)68:1<111::AID-CNCR2820680122>3.0.CO;2-E","volume":"68","author":"K Nishida","year":"1991","unstructured":"Nishida K, Yamamoto H, Ohtsuki T, Matsuba M, Mukai S, Naito Y, Yoshikawa T, Kondo M: Elevated tissue concentrations of sialyl Lex-i in cancerous tissues compared with those in noncancerous tissues of various organs. Cancer. 1991, 68: 111-117. 10.1002\/1097-0142(19910701)68:1<111::AID-CNCR2820680122>3.0.CO;2-E.","journal-title":"Cancer"},{"key":"1498_CR34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.lungcan.2007.07.002","volume":"58","author":"S Mizuguchi","year":"2007","unstructured":"Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Uenishi T, Wakasa K, Suehiro S: Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer. Lung Cancer. 2007, 58: 369-375. 10.1016\/j.lungcan.2007.07.002.","journal-title":"Lung Cancer"},{"key":"1498_CR35","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1245\/ASO.2006.05.018","volume":"13","author":"S Mizuguchi","year":"2006","unstructured":"Mizuguchi S, Inoue K, Iwata T, Nishida T, Izumi N, Tsukioka T, Nishiyama N, Uenishi T, Suehiro S: High serum concentrations of Sialyl Lewisx predict multilevel N2 disease in non-small-cell lung cancer. Ann Surg Oncol. 2006, 13: 1010-1018. 10.1245\/ASO.2006.05.018.","journal-title":"Ann Surg Oncol"},{"key":"1498_CR36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.athoracsur.2006.08.042","volume":"83","author":"S Mizuguchi","year":"2007","unstructured":"Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Kameyama M, Suehiro S: Clinical value of serum cytokeratin 19 fragment and sialyl-Lewis x in non-small cell lung cancer. Ann Thorac Surg. 2007, 83: 216-221. 10.1016\/j.athoracsur.2006.08.042.","journal-title":"Ann Thorac Surg"},{"key":"1498_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0169-5002(98)00016-6","volume":"20","author":"K Fukuoka","year":"1998","unstructured":"Fukuoka K, Narita N, Saijo N: Increased expression of sialyl Lewis(x) antigen is associated with distant metastasis in lung cancer patients: immunohistochemical study on bronchofiberscopic biopsy specimens. Lung Cancer. 1998, 20: 109-116. 10.1016\/S0169-5002(98)00016-6.","journal-title":"Lung Cancer"},{"key":"1498_CR38","first-page":"495","volume":"3","author":"H Satoh","year":"1997","unstructured":"Satoh H, Ishikawa H, Kamma H, Yamashita YT, Takahashi H, Ohtsuka M, Hasegawa S: Serum sialyl lewis X-i antigen levels in non-small cell lung cancer: correlation with distant metastasis and survival. Clin Cancer Res. 1997, 3: 495-499.","journal-title":"Clin Cancer Res"},{"key":"1498_CR39","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000029279","volume":"65","author":"H Satoh","year":"1998","unstructured":"Satoh H, Ishikawa H, Kamma H, Yamashita YT, Takahashi H, Ohtsuka M, Hasegawa S: Elevated serum sialyl Lewis X-i antigen levels in non-small cell lung cancer with lung metastasis. Respiration. 1998, 65: 295-298. 10.1159\/000029279.","journal-title":"Respiration"},{"key":"1498_CR40","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.jtcvs.2007.10.034","volume":"135","author":"M Inoue","year":"2008","unstructured":"Inoue M, Takakuwa T, Minami M, Shiono H, Utsumi T, Kadota Y, Nasu T, Aozasa K, Okumura M: Clinicopathologic factors influencing postoperative prognosis in patients with small-sized adenocarcinoma of lung. J Thorac Cardiovasc Surg. 2008, 135: 830-836. 10.1016\/j.jtcvs.2007.10.034.","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-11-309.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:26:12Z","timestamp":1630549572000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/1477-7819-11-309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1498"],"URL":"https:\/\/doi.org\/10.1186\/1477-7819-11-309","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"17 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"309"}}